Seletracetam (ucb 44212) inhibits high-voltage-activated Ca2+ currents and intracellular Ca2+ increase in rat cortical neurons in vitro

Epilepsia

Volumn 50, Issue 4, 2009, Pages 702-710

  Martella, Giuseppina ^a   Bonsi, Paola ^a   Sciamanna, Giuseppe ^a   Platania, Paola ^a   Madeo, Graziella ^a   Tassone, Annalisa ^a   Cuomo, Dario ^a   Pisani, Antonio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Acutely dissociated neuron; Calcium imaging; Epileptiform activity; Levetiracetam; Pyramidal neuron; Slice

Indexed keywords

CALCIUM; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL Q TYPE; ETIRACETAM; OMEGA CONOTOXIN GVIA; OMEGA CONOTOXIN MVIIC; SELETRACETAM;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN SLICE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CONTROLLED STUDY; DRUG STRUCTURE; EPILEPTIC DISCHARGE; IN VITRO STUDY; MALE; NERVE CELL MEMBRANE STEADY POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RAT;

4-AMINOPYRIDINE; ANIMALS; ANTICONVULSANTS; BICUCULLINE; BIOPHYSICS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA ANTAGONISTS; MAGNESIUM; MALE; MEMBRANE POTENTIALS; NEOCORTEX; NEURAL INHIBITION; NEURONS; PATCH-CLAMP TECHNIQUES; PIRACETAM; POTASSIUM CHANNEL BLOCKERS; PYRROLIDINONES; RATS; RATS, WISTAR;

EID: 64049087839     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2008.01915.x     Document Type: Article

References (38)

1. Albowitz B, Konig P, Kuhnt U 1997) Spatiotemporal distribution of intracellular calcium transients during epileptiform activity in guinea pig hippocampal slices. J Neurophysiol 77 : 491 501.
2. 2+ transients and epileptiform potentials in hippocampal neurons. NeuroReport 14 : 471 475.
3. Avanzini G, Franceschetti S 2003) Cellular biology of epileptogenesis. Lancet Neurol 2 : 33 42.
4. Badea T, Goldberg J, Mao B, Yuste R 2001) Calcium imaging of epileptiform events with single-cell resolution. J Neurobiol 48 : 215 227.
5. Beck H, Steffens R, Elger CE, Heinemann U 1998) Voltage-dependent Ca2+ currents in epilepsy. Epilepsy Res 32 : 321 332.
6. Bennett B, Matagne A, Michel P, Leonard M, Cornet M, Meeus M-A, Toublanc N 2007) Seletracetam (UCB 44212). Neurotherapeutics 4 : 117 122.
7. Berger T, Larkum ME, Luscher H-R 2001) High Ih channel density in the distal apical dendrite of layer V pyramidal cells increases bidirectional attenuation of EPSPs. J Neurophysiol 85 : 855 868.
8. Connors BW, Giutnick MJ, Prince DA 1982) Electrophysiological properties of neocortical neurons in vitro. J Neurophysiol 48 : 1302 1320.
9. de Curtis M, Avanzini G 2001) Interictal spikes in focal epileptogenesis. Prog Neurobiol 63 : 541 567.
10. Custer KL, Austin NS, Sullivan JM, Bajjalieh SM 2006) Synaptic vesicle protein 2 enhances release probability at quiescent synapses. J Neurosci 26 : 1303 1313.
11. Day M, Carr DB, Ulrich S, Ilijic E, Tkatch T, Surmeier DJ 2005) Dendritic excitability of mouse frontal cortex pyramidal neurons is shaped by the interaction among HCN, Kir2, and Kleak channels. J Neurosci 25 : 8776 8787.
12. Hainsworth AH, Spadoni F, Lavaroni F, Bernardi G, Stefani A 2001) Effects of extracellular pH on the interaction of sipatrigine and lamotrigine with high-voltage-activated (HVA) calcium channels in dissociated neurones of rat cortex. Neuropharmacology 40 : 784 791.
13. Kostyuk PG, Lukyanetz EA, Klitgaard H, Margineanu D-G 2004) UCB 34714, a new pyrrolidone derivative, without impact on high- and low-voltage activated calcium currents in rat isolated neurons. Epilepsia 45 (Suppl. 7 141.
14. Kwan P, Brodie MJ 2000) Early identification of refractory epilepsy. New Engl J Med 342 : 314 319.
15. Lukyanetz EA, Shkryl VM, Kostyuk PG 2002) Selective blockade of N-type calcium channels by levetiracetam. Epilepsia 43 : 9 18.
16. Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B 2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 101 : 9861 9866.
17. Martella G, De Persis C, Bonsi P, Natoli S, Cuomo D, Bernardi G, Calabresi P, Pisani A 2005) Inhibition of persistent sodium current fraction and voltage-gated L-type calcium current by propofol in cortical neurons: implications for its antiepileptic activity. Epilepsia 46 : 624 635.
18. Matagne A, Margineanu DG, Michel P, Kenda B, Klitgaard H 2005) Seletracetam (ucb 44212), a new pyrrolidone derivative, reveals potent activity in in vitro and in vivo models of epilepsy. J Neurol Sci 238 (Suppl. 1 S133.
19. Matagne A, Margineanu D-G, Kenda B, Michel P, Klitgaard H 2008) Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A. Br J Pharmacol 154 : 1662 1671.
20. Matsumoto H, Ajmone-Marsan C 1964) Cortical cellular phenomena in experimental epilepsy: ictal manifestations. Exp Neurol 9 : 305 326.
21. Maurice N, Tkatch T, Meisler M, Sprunger LK, Surmeier DJ 2001) D1/D5 dopamine receptor activation differentially modulates rapidly inactivating and persistent sodium currents in prefrontal cortex pyramidal neurons. J Neurosci 21 : 2268 2277.
22. McNamara JO 2006) Pharmacotherapy of the epilepsies. Ch. 19. In Brunton LL, Lazo JS, Parker KL (Eds) Goodman & Gilman's the pharmacological basis of therapeutics. 11th ed. McGraw-Hill, New York, pp. 501 525.
23. Moreno H, Rudy B, Llinas R 1997) Beta subunits influence the biophysical and pharmacological differences between P- and Q-type calcium currents expressed in a mammalian cell line. Proc Natl Acad Sci USA 94 : 14042 14047.
24. 2+ current in CA1 pyramidal neurones of rat hippocampal slices. Neurosci Lett 306 : 5 8.
25. Pape HC 1996) Queer current and pacemaker: the hyperpolarization- activated cation current in neurons. Annu Rev Physiol 58 : 299 327.
26. Patsalos PN 2000) Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther 85 : 77 85.
27. Phillips PE, Stamford JA 2000) Differential recruitment of N-, P- and Q-type voltage-operated calcium channels in striatal dopamine release evoked by 'regular' and 'burst' firing. Brain Res 884 : 139 146.
28. Pisani A, Bonsi P, Martella G, De Persis C, Costa C, Pisani F, Bernardi G, Calabresi P 2004) Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine. Epilepsia 45 : 719 728.
29. 2+] increase in rat cortical neurons in vitro. Epilepsia 46 (Suppl. 8 119.
30. Randall A, Tsien RW 1995) Pharmacological dissection of multiple types of Ca2+ channel currents in rat cerebellar granule neurons. J Neurosci 15 : 2995 3012.
31. Rogawski MA, Löscher W 2004) The neurobiology of antiepileptic drugs. Nat Rev Neurosci 5 : 553 564.
32. Schwindt P, O'Brien JA, Crill W 1997) Quantitative analysis of firing properties of pyramidal neurons from layer 5 of rat sensorimotor cortex. J Neurophysiol 77 : 2484 2498.
33. Siniscalchi A, Calabresi P, Mercuri NB, Bernardi G 1997) Epileptiform discharge induced by 4-aminopyridine in magnesium-free medium in neocortical neurons: physiological and pharmacological characterization. Neuroscience 81 : 189 197.
34. Stefan H, Feuerstein TJ 2007) Novel anticonvulsant drugs. Pharmacol Ther 113 : 165 183.
35. 2+ currents in cortical neurons: functional implications. Eur J Pharmacol 307 : 113 116.
36. Zhang ZW 2004) Maturation of layer V pyramidal neurons in the rat prefrontal cortex: intrinsic properties and synaptic function. J Neurophysiol 91 : 1171 1182.
37. 2+ currents. Seizure 10 : 279 286.
38. + currents in rat brain neurons in vitro. Epilepsia 46 (Suppl. 8 116.